Wikidata

(Q39229103)

English

Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study

scientific article published on 9 April 2013

In more languages

Statements

title
Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
23583433
retrieved
10 September 2017
author name string
Leonard S Dove
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
23583433
retrieved
10 September 2017
Anthony Lembo
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
23583433
retrieved
10 September 2017
Charles W Randall
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
23583433
retrieved
10 September 2017
Ronald Fogel
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
23583433
retrieved
10 September 2017
David Andrae
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
23583433
retrieved
10 September 2017
J Michael Davenport
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
23583433
retrieved
10 September 2017
Gail McIntyre
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
23583433
retrieved
10 September 2017
June S Almenoff
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
23583433
retrieved
10 September 2017
Paul S Covington
series ordinal
9
1 reference
stated in
Europe PubMed Central
PubMed ID
23583433
retrieved
10 September 2017
publication date
9 April 2013
1 reference
stated in
Europe PubMed Central
PubMed ID
23583433
retrieved
10 September 2017
page(s)
329-38.e1
1 reference
stated in
Europe PubMed Central
PubMed ID
23583433
retrieved
10 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q39229103&oldid=2088848042"